Morgan Stanley analyst Robert Kad downgrades DT Midstream (NYSE:DTM) from Equal-Weight to Underweight and announces $54 price target.
Calliditas Takes 100% Control Of Genkyotex
Swedish drugmaker Calliditas Therapeutics AB (NASDAQ:CALT) has now taken complete control of Genkyotex after completing a centralized squeeze-out offer to all minority shareholders. Deal…